BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20626026)

  • 21. Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF(2alpha) may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications.
    Dreissigacker U; Suchy MT; Maassen N; Tsikas D
    Clin Biochem; 2010 Jan; 43(1-2):159-67. PubMed ID: 19850019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of methods for the measurement of 8-isoPGF(2α): a marker of oxidative stress.
    Smith KA; Shepherd J; Wakil A; Kilpatrick ES
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):147-54. PubMed ID: 21292864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum total 8-iso-prostaglandin F2alpha: a new and independent predictor of peripheral arterial disease.
    Mueller T; Dieplinger B; Gegenhuber A; Haidinger D; Schmid N; Roth N; Ebner F; Landl M; Poelz W; Haltmayer M
    J Vasc Surg; 2004 Oct; 40(4):768-73. PubMed ID: 15472607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology.
    Taylor AW; Bruno RS; Traber MG
    Lipids; 2008 Oct; 43(10):925-36. PubMed ID: 18751751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
    Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
    J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases.
    Basu S; Whiteman M; Mattey DL; Halliwell B
    Ann Rheum Dis; 2001 Jun; 60(6):627-31. PubMed ID: 11350853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrite correlates with 3-nitrotyrosine but not with the F(2)-isoprostane 15(S)-8-iso-PGF(2alpha) in urine of rheumatic patients.
    Pham VV; Stichtenoth DO; Tsikas D
    Nitric Oxide; 2009; 21(3-4):210-5. PubMed ID: 19737619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography.
    Tsikas D; Suchy MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():191-201. PubMed ID: 25583542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet activation in obese women: role of inflammation and oxidant stress.
    Davì G; Guagnano MT; Ciabattoni G; Basili S; Falco A; Marinopiccoli M; Nutini M; Sensi S; Patrono C
    JAMA; 2002 Oct 23-30; 288(16):2008-14. PubMed ID: 12387653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.
    Yin H; Gao L; Tai HH; Murphey LJ; Porter NA; Morrow JD
    J Biol Chem; 2007 Jan; 282(1):329-36. PubMed ID: 17107953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
    Proudfoot J; Barden A; Mori TA; Burke V; Croft KD; Beilin LJ; Puddey IB
    Anal Biochem; 1999 Aug; 272(2):209-15. PubMed ID: 10415090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin E supplementation decreases basal levels of F(2)-isoprostanes and prostaglandin f(2alpha) in rats.
    Södergren E; Cederberg J; Basu S; Vessby B
    J Nutr; 2000 Jan; 130(1):10-4. PubMed ID: 10613758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort.
    Lin HJ; Chen ST; Wu HY; Hsu HC; Chen MF; Lee YT; Wu KY; Chien KL
    Int J Cardiol; 2015 Mar; 183():214-20. PubMed ID: 25675904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of the oxidative damage biomarker 2,3-dinor-8-isoprostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
    Zhang H; Il'yasova D; Sztaray J; Young SP; Wang F; Millington DS
    Anal Biochem; 2010 Apr; 399(2):302-4. PubMed ID: 20026293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of dinor, dihydro metabolites of F2-isoprostanes in urine by liquid chromatography/tandem mass spectrometry.
    Davies SS; Zackert W; Luo Y; Cunningham CC; Frisard M; Roberts LJ
    Anal Biochem; 2006 Jan; 348(2):185-91. PubMed ID: 16309621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
    Fahlbusch SA; Tsikas D; Mehls C; Gutzki FM; Böger RH; Frölich JC; Stichtenoth DO
    Eur J Clin Pharmacol; 2004 Apr; 60(2):83-8. PubMed ID: 15004731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid chromatography-high resolution mass spectrometry with immunoaffinity clean-up for the determination of the oxidative stress biomarker 8-iso-prostaglandin F2alpha in wastewater.
    Ryu Y; Reid MJ; Thomas KV
    J Chromatogr A; 2015 Aug; 1409():146-51. PubMed ID: 26231523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of urinary 8-isoprostane as an oxidative stress biomarker by stable isotope dilution using automated online in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry.
    Mizuno K; Kataoka H
    J Pharm Biomed Anal; 2015 Aug; 112():36-42. PubMed ID: 25956225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Packed-Fiber Solid Phase-Extraction Coupled with HPLC-MS/MS for Rapid Determination of Lipid Oxidative Damage Biomarker 8-Iso-Prostaglandin F
    Sun Y; Yan Y; Kang X
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease.
    Wang B; Pan J; Wang L; Zhu H; Yu R; Zou Y
    Atherosclerosis; 2006 Feb; 184(2):425-30. PubMed ID: 15996671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.